Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients

D. Mahadevan, Monica Mita, Donald Richards, Edward McClay, Rebecca Suk Heist, A. Kumar, S. Sundararajan, Aung Naing

Producción científica: Article › revisión exhaustiva

5 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science